Filing Details
- Accession Number:
- 0001127602-18-005574
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-13 17:24:29
- Reporting Period:
- 2018-02-09
- Accepted Time:
- 2018-02-13 17:24:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1198227 | E Gayle Wilson | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-09 | 60,000 | $26.62 | 182,258 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-09 | 60,000 | $77.92 | 122,258 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2018-02-09 | 60,000 | $0.00 | 60,000 | $26.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-05-08 | No | 4 | M | Direct |
Footnotes
- Sale prices reported for the transactions reported here range from $77.88 to $78.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Options vest 100% on the first anniversary date of the grant.
Billionaire Hedge Funds
